Increased number of Biohit shares entered into trade register
Biohit Oyj Stock Exchange Release November 20, 2013 at 8:30 a.m. local time (EET)
New B-share subscriptions, total 15.000 pcs, based on the company's stock option program II 2013 approved by the Board of Directors of Biohit Oyj on October 6, 2013, have been entered into the trade register today. The share subscription price was three (3) euros per share. The nominal value of the share, 2.550 euros, will be recorded in equity and the rest (42.450 euros) in the invested unrestricted equity fund.
After the subscriptions (15.000 shares), the number of all Biohit Oyj's shares will rise into 13.810.593 shares (13.795.593) and B-shares will rise into 10.835.093 (10.820.093). The company's share capital will increase from 2,345,250.81 euros to 2,347,800.81 euros.
The new shares will correspond to a percentage of 0.1% of the Biohit Oyj's total number of shares and 0.02% of the share of voting rights after registration.
Biohit Oyj has applied for the listing of its new shares on the NASDAQ OMX Helsinki in the same series as the company's existing shares. The new shares will be listed on November 21, 2013.
Additional information:
CEO Semi Korpela, Biohit Oyj
Tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”. The purpose of the company is to take social responsibility and produce innovation, new technologies and analysis systems for use in medicine, research institutions and industry, helping to promote research and diagnostics and to improve people’s quality of life by preventing disease, human suffering and financial loss. We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in China, Italy and the United Kingdom. Since 1999, Biohit’s series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector. www.biohithealthcare.com
|